» Articles » PMID: 27531895

Mammalian Eps15 Homology Domain 1 Promotes Metastasis in Non-small Cell Lung Cancer by Inducing Epithelial-mesenchymal Transition

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Aug 18
PMID 27531895
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The identification of the earliest molecular events responsible for the metastatic dissemination of non-small cell lung cancer (NSCLC) remains critical for early detection, prevention, and treatment interventions. In this study, we hypothesized that Mammalian Eps15 homology domain 1 (EHD1) might be responsible for the metastatic behavior of cells in NSCLC. We demonstrated that upregulation of EHD1 is associated with lymph nodes metastasis and unfavorable survival in patients with NSCLC. EHD1 knockdown inhibited the invasion and migration of human NSCLC cells, and overexpression of EHD1 increased the metastatic potential of lung cancer cells. Using the Affymetrix Human Gene 1.0 ST platform, microarray analysis revealed that an association between EHD1 and epithelial-mesenchymal transition (EMT), supported by downregulation of mesenchymal markers and upregulation of epithelial markers following knockdown of EHD1 in cell lines. Moreover, overexpression of EHD1 induced the EMT and increased the metastatic potential of lung cancer cells in vitro and in vivo. These results provide a model to illustrate the relationship between EHD1 expression and lung cancer metastasis, opening up new avenues for the prognosis and therapy of lung cancer.

Citing Articles

EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis.

Chakraborty S, Bhat A, Mushtaq I, Luan H, Kalluchi A, Mirza S Commun Biol. 2023; 6(1):758.

PMID: 37474760 PMC: 10359273. DOI: 10.1038/s42003-023-05125-1.


A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma.

Liu Y, Song Y, Cao M, Fan W, Cui Y, Cui Y Clin Transl Med. 2022; 12(4):e836.

PMID: 35485206 PMC: 9786223. DOI: 10.1002/ctm2.836.


Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies.

Santarpia M, Aguilar A, Chaib I, Cardona A, Fancelli S, Laguia F Cancers (Basel). 2020; 12(6).

PMID: 32516941 PMC: 7352732. DOI: 10.3390/cancers12061475.


USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression.

Han B, Sun Y, Yang D, Zhang H, Mo S, Chen X Aging (Albany NY). 2020; 12(8):6990-7005.

PMID: 32294625 PMC: 7202522. DOI: 10.18632/aging.103056.


Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.

Huang J, Lan X, Wang T, Lu H, Cao M, Yan S Oncogene. 2019; 39(8):1739-1755.

PMID: 31740781 DOI: 10.1038/s41388-019-1099-5.


References
1.
Zhang Y, Liu S, Wang L, Wu Y, Hao J, Wang Z . A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth. Cancer Lett. 2016; 375(1):179-189. DOI: 10.1016/j.canlet.2016.02.049. View

2.
Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

3.
Shin J, Monti S, Aires D, Duvic M, Golub T, Jones D . Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Blood. 2007; 110(8):3015-27. PMC: 2018675. DOI: 10.1182/blood-2006-12-061507. View

4.
Vinson K, George D, Fender A, Bertrand F, Sigounas G . The Notch pathway in colorectal cancer. Int J Cancer. 2015; 138(8):1835-42. DOI: 10.1002/ijc.29800. View

5.
Kang Y, Massague J . Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004; 118(3):277-9. DOI: 10.1016/j.cell.2004.07.011. View